Sort
326,823 grants matching “clinical trial”
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)
$1,774,823Matthew S Freiberg · Vanderbilt University Medical Center · P01 · FY2024 · AA
HIV VACCINE CLINICAL TRIALS UNIT
$1,774,800Vanderbilt University · U01 · FY2001 · AI
CABANA-AF Trial
$1,774,736Kerry L Lee · Duke University · U01 · FY2009 · HL
Protein Structure
$1,774,669Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Immune Responses To AAV-Mediated FIX Gene Transfer
$1,774,656Hildegund C. J. Ertl · Wistar Institute · P01 · FY2009 · HL
HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER
$1,774,648Saint Louis University · U01 · FY2004 · AI
Innovative Approaches for Cocaine Pharmacotherapy
$1,774,287Helen M Pettinati · University Of Pennsylvania · P50 · FY2010 · DA
GEORGETOWN-HOWARD UNIVERSITIES CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE (GH
$1,774,238Joseph G Verbalis · Georgetown University · UL1 · FY2010 · RR
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
$1,774,215David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2019 · HL
UNM Metals Exposure and Toxicity Assessment on tribal Lands in the Southwest (METALS) Superfund Research Program
$1,774,184Jose Manuel Cerrato · University Of New Mexico Health Scis Ctr · P42 · FY2024 · ES
Point Detection of Pathogens in Oral Samples via UPT
$1,774,102Daniel Malamud · New York University · U01 · FY2010 · DE
Vaccine and Treatment Evaluation Units (VTEU)
$1,774,060Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2020 · AI
Orthopox immunization in patients with cancer or eczema
$1,773,663Dana-Farber Cancer Institute · U19 · FY2003 · AI
Epidemiologic Field Studies
$1,773,652Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
SPORE in Prostate Cancer
$1,773,356Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
FOcal Cerebral Arteriopathy Steroids (FOCAS) Trial
$1,773,264Heather J Fullerton · University Of California, San Francisco · UG3 · FY2023 · NS
New therapeutic vulnerabilities in breast cancer
$1,772,970Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2020 · CA
PACT
$1,772,862Jason Jacobs · University Of Minnesota · N01 · FY2014 · HL
A Massive Library of AAVs to Target Transcriptionally-Defined Primate Cell Types
$1,772,291William Richard Stauffer · University Of Pittsburgh At Pittsburgh · UG3 · FY2020 · MH
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
$1,772,232Kathleen N. Moore · University Of Oklahoma Hlth Sciences Ctr · UG1 · FY2020 · CA
OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T
$1,772,024Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2020 · DA
Washington University Human Tumor Atlas Research Center
$1,771,881Li Ding · Washington University · U2C · FY2020 · CA
Washington University Human Tumor Atlas Research Center
$1,771,877Li Ding · Washington University · U2C · FY2021 · CA
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN)
$1,771,863Diane V Havlir · University Of California, San Francisco · UG3 · FY2018 · HD
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome
$1,771,855Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2024 · CA